LawFinance Limited (ASX:LAW), formerly JustKapital Limited, is an Australia-based diversified financing company that specializes in providing litigation and legal finance solutions primarily to law firms and corporate claimants in the United States. The company offers a range of tailored funding products including PortfolioFinance® and FirmFinance® for high-value commercial and intellectual property litigation portfolios on a cross-collateralized basis; AppealFinance® for post-judgment appellate litigation at state and federal levels; single-case funding to cover legal fees or monetize interests in individual high-value cases; and legacy services such as medical lien funding and disbursement funding for personal injury claims. It operates through segments encompassing short-term funding and National Health Finance, targeting law firms, corporate legal departments, and medical providers with flexible solutions at any litigation stage to mitigate risks, meet capital needs, and optimize legal assets.
Founded in 1999 and listed on the ASX since May 2000, LawFinance Limited maintains its headquarters in Five Dock, New South Wales, Australia, with principal operations focused on the U.S. legal market through subsidiaries. The company does not pay dividends and employs approximately 43 staff, serving clients in commercial disputes involving business-to-business claims, breaches of fiduciary duties, intellectual property infringement, negligence, and securities law matters.
In recent developments, LawFinance Limited continues to emphasize its U.S.-centric legal finance expansion following the 2018 name change from JustKapital and acquisition of U.S. operations, with leadership recognitions in 2025 including CEO Kevin McCaffrey, Grant Schrader, and Lauren Harrison named as Lawdragon 100 Global Leaders in Litigation Finance. The company remains active in industry events, such as panels at the 2025 LVNx Conference and CAC's CRICON, highlighting integration of litigation finance into law firm strategies amid ongoing share price suspension and low trading volumes as of 2025. No major acquisitions, funding rounds, or new product launches have been announced in the last 1-2 years, with focus on operational stability and ethical funding practices per its Code of Ethics.